“If you were to say, tell me the characteristics of a perfect drug to treat COVID-19, what would you ask for? I think you would ask firstly for something that’s safe, that’s cheap, that’s readily available, and has anti-viral and anti-inflammatory properties. People would say, “That’s ridiculous. There could not possibly be a drug that has all of those characteristics. That’s just unreasonable. But we do have such a drug. The drug is called Ivermectin.”
(Professor Paul Marik, Eastern Virginia Medical School)
“Capuzzo, a six-time Pulitzer-nominated journalist best known for his New York Times-bestselling nonfiction books Close to Shore and Murder Room, ended up publishing his article on ivermectin in Mountain Home, a monthly local magazine for the of the Pennsylvania mountains and New York Finger Lakes region, of which Capuzzo’s wife is the editor. It’s also the reason why I decided to dedicate today’s post to Capuzzo’s article. Put simply, as many people as possible –particularly journalists — need to read his story.” (Nick Corbishley, https://www.nakedcapitalism.com/2021/05/i-dont-know-of-a-bigger-story-in-the-world-right-now-than-ivermectin-ny-times-best-selling-author.html )
My take on it
This is a story of hope, beautifully told. It waits on a happy ending.
It is also a savage indictment of many, particularly amongst politicians, biocrats, big pharma and the media, who have had an exceptional opportunity to make a real difference, and have chosen not to.
God’s word tells us, “Do not withhold good from those to whom it is due, when it is in your power to act.” (Prov 3:27)
This is a flagrant case of withholding good, on an unprecedented scale, from those to whom it is due.
So the question naturally arises, as to Why?
According to Nick Corbishley there are three possible explanations for health regulators’ refusal to allow the use of a highly promising, well-tolerated off-label medicine such as ivermectin:
- As a generic, ivermectin is cheap and widely available, which means there would be a lot less money to be made by Big Pharma if it became the go-to early-stage treatment against covid.
- Other pharmaceutical companies are developing their own novel treatments for Covid-19 which would have to compete directly with ivermectin. They include ivermectin’s original manufacturer, Merck, which has an antiviral compound, molnupiravir, in Phase 3 clinical trials for COVID-19. That might explain the company’s recent statement claiming that there is “no scientific basis whatsoever for a potential therapeutic effect of ivermectin against COVID-19.
- If approved as a covid-19 treatment, ivermectin could even threaten the emergency use authorisation granted to covid-19 vaccines. One of the basic conditions for the emergency use authorisation granted to the vaccines currently being used against covid is that there are no alternative treatments available for the disease. As such, if ivermectin or some other promising medicine such as fluvoxamine were approved as an effective early treatment for Covid-19, the vaccines could be stripped of authorisation.
.Well, Nick, let’s just say That’s a start.